Renascience

Renascience Operating Expenses

The Total Operating Expenses of Renascience (4889.T) as of Nov 19, 2026 is 180.87 M JPY. In the previous year, Total Operating Expenses was 284.00 M JPY — a change of -36.31% (lower).

Operating Expenses

180.87 MJPY

YoY

-36.31%

Last updated:

Total Operating Expenses of Renascience is 2025 180.87 M JPY. Total Operating Expenses of Renascience was 2024 284.00 M JPY. It decreases by -36.31% lower compared to the previous year.

The Renascience Operating Expenses history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Operating Expenses
Date
Operating Expenses
Jan 1, 2020
26.00 M JPY
Jan 1, 2021
263.08 M JPY
Jan 1, 2022
135.71 M JPY
Jan 1, 2023
285.00 M JPY
Jan 1, 2024
284.00 M JPY
Jan 1, 2025
180.87 M JPY
The Renascience Operating Expenses history
YEAROperating ExpensesYoY
180.87 MJPY-36.31%
284.00 MJPY-0.35%
285.00 MJPY+110.00%
135.71 MJPY-48.41%
263.08 MJPY+911.70%
26.00 MJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Renascience Stock analysis

What does Renascience do? Renascience, Inc. develops and sells pharmaceuticals, focusing on drugs for four non-infectious aging-related diseases: cancer, diabetes, respiratory diseases, and cardiovascular diseases. The company collaborates with physicians in research and development of pharmaceuticals, medical devices, and AI solutions for medical problems. Its products target aging-related health issues, including women's and children's diseases and solutions for COVID-19 infection. The firm's revenue comes from the sale of developed pharmaceuticals, medical devices, and AI solutions. Physicians and medical institutions are key buyers of its products, as the company's R&D is conducted in collaboration with them. The primary market segments are aging populations suffering from chronic conditions and healthcare providers seeking innovative medical solutions. Renascience, Inc. operates with a small team of three full-time employees, emphasizing focused R&D on specific medical challenges. Its business model centers on developing targeted therapies for high-impact diseases, leveraging partnerships with physicians to address unmet medical needs in aging-related health conditions. Renascience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Renascience stock

Total Operating Expenses of Renascience is 180.87 M JPY in 2025.

Total Operating Expenses of Renascience changed from 284.00 M JPY to 180.87 M JPY, representing a -36.31% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Total Operating Expenses Renascience since 2006 – with annual values, charts, and detailed analysis.

Operating expenses are the costs incurred in the normal course of business operations, including COGS, SG&A, R&D, and depreciation.

Total Operating Expenses's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Total Operating Expenses's Renascience historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Renascience

All Key Metrics — Renascience